서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 60 of 118

Issue DateTitle / Author(s) / CitationFileAltmetrics
2005-07
Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer
DOI
2005-09
행정책무성에 대한 조직문화 유형별 영향요인 분석

이환범; 김태영; 이수창

행정논총, Vol. 43 No. 3, pp. 29-52

view file
2011-06
Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis
DOI
2011-10
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting

Lim, Kyu-Hyoung; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

Cancer Chemotherapy and Pharmacology, Vol.68 No.4, pp.1017-1026

DOI
2012-12
Body Mass Index Is Not Associated with Treatment Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Korean Data
view fileDOI
2013-03
Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors
DOI
2013-05
Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing
DOI
2013-05
Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer
DOI
2013-07
HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer
DOI
2013-11
Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy
DOI
2014-01
Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker
DOI
2014-07
The Impact of Body Mass Index Dynamics on Survival of Patients With Advanced Pancreatic Cancer Receiving Chemotherapy

Choi, Younak; Kim, Tae-Yong; Lee, Kyung-hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

Journal of Pain and Symptom Management, Vol.48 No.1, pp.13-25

DOI
2014-07
A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions
DOI
2014-09
Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer
DOI
2015-01
KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX
DOI
2015-03
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells
view fileDOI
2015-03
Predictive significance of p53, Ki-67, and Bcl-2 expression for pathologic complete response after neoadjuvant chemotherapy for triple-negative breast cancer
DOI
2015-03
Treatment for unresectable gastric cancer

Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue

대한의사협회지, Vol.58 No.3, pp.209-215

DOI
2015-03
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells
view fileDOI
2015-04
Nomogram for predicting breast conservation after neoadjuvant chemotherapy
DOI
2015-06
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
DOI
2015-06
Optimal patient selection for trastuzumab treatment in HER2-positive advanced gastric cancer
DOI
2015-07
Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX
view fileDOI
2015-07
Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype
DOI
2015-08
Metabolic characteristics of advanced biliary tract cancer using F-18-fluorodeoxyglucose positron emission tomography and their clinical implications
DOI
2015-10
Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients
view fileDOI
2015-10
Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma
view fileDOI
2015-10
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index
DOI
2015-11
The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer
2015-12
Capecitabine for the treatment of gastric cancer

Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue

Expert Review of Gastroenterology and Hepatology, Vol.9 No.12, pp.1471-1481

DOI
2016-01
The impact of diabetes mellitus and metformin treatment on survival of patients with advanced pancreatic cancer undergoing chemotherapy

Choi, Younak; Kim, Tae-Yong; Oh, Do-Youn; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

Cancer Research and Treatment, Vol.48 No.1, pp.171-179

DOI
2016-01
More accurate prediction of metastatic pancreatic cancer patients' survival with prognostic model using both host immunity and tumor metabolic activity
DOI
2016-01
Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer

Kim, Ji-Won; Kim, Debora K.; Min, Ahrum; Lee, Kyung-Hun; Nam, Hyun-Jin; Kim, Jee Hyun; Kim, Jin-Soo; Kim, Tae-Yong; Im, Seock-Ah; Park, In Ae

Journal of Cancer Research and Clinical Oncology, Vol.142 No.1, pp.157-165

DOI
2016-02
Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer
DOI
2016-03
Survival outcomes according to adjuvant treatment and prognostic factors including host immune markers in patients with curatively resected ampulla of vater cancer
DOI
2016-03
Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
DOI
2016-04
Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer
DOI
2016-04
Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications
DOI
2016-04
Is there any role of adjuvant chemotherapy for T3N0M0 or T1N2M0 gastric cancer patients in stage II in the 7th TNM but stage I in the 6th TNM system?
DOI
2016-06
Prognostic role of body mass index in advanced small bowel adenocarcinoma patients receiving palliative chemotherapy
DOI
2016-07
Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer
DOI
2016-07
Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX
DOI
2016-07
Concurrent chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: A retrospective cohort study
DOI
2016-07
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
DOI
2016-07
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer
DOI
2016-07
Early prediction of response to neoadjuvant chemotherapy in breast cancer patients: comparison of single-voxel H-1-magnetic resonance spectroscopy and F-18-fluorodeoxyglucose positron emission tomography
DOI
2016-07
Src as a Therapeutic Target in Biliary Tract Cancer
DOI
2016-08
Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer
DOI
2016-08
Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study

Lee, Dong Ho; Kim, Se Hyung; Im, Seock-Ah; Oh, Do-Youn; Kim, Tae-Yong; Han, Joon Koo

European Radiology, Vol.26 No.8, pp.2771-2778

DOI
2016-09
Therapeutic implication of HER2 in advanced biliary tract cancer
DOI
2016-10
Prognostic value of axillary nodal ratio after neoadjuvant chemotherapy of doxorubicin/cyclophosphamide followed by docetaxel in breast cancer: A multicenter retrospective cohort study
DOI
2016-10
Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
DOI
2016-11
Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy
DOI
2016-11
TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials
DOI
2017-01
Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer
DOI
2017-01
Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer
DOI
2017-03
Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer
DOI
2017-03
Optimal Timing of Influenza Vaccination During 3-Week Cytotoxic Chemotherapy Cycles
DOI
2017-04
Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea
DOI
2017-04
Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of lmatinib and Sunitinib: A Multicenter Study Based on the Management Access Program
DOI
1 2